Home/Filings/4/0000950170-25-012579
4//SEC Filing

CRANDELL KEITH 4

Accession 0000950170-25-012579

CIK 0002040807other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 7:01 PM ET

Size

36.2 KB

Accession

0000950170-25-012579

Insider Transaction Report

Form 4
Period: 2025-02-03
Transactions
  • Conversion

    Series Seed Preferred Stock

    2025-02-0319,933,3330 total(indirect: See Footnote)
    Common Stock (8,483,268 underlying)
  • Conversion

    Common Stock

    2025-02-03+7,523,6827,523,682 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,730 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
  • Conversion

    Common Stock

    2025-02-03+16,006,94917,070,904 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+789,998$14,219,9648,313,680 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,731 underlying)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+1,432,224$25,780,03218,503,128 total(indirect: See Footnote)
Transactions
  • Conversion

    Common Stock

    2025-02-03+16,006,94917,070,904 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+789,998$14,219,9648,313,680 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
  • Conversion

    Common Stock

    2025-02-03+7,523,6827,523,682 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,730 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,731 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
  • Conversion

    Series Seed Preferred Stock

    2025-02-0319,933,3330 total(indirect: See Footnote)
    Common Stock (8,483,268 underlying)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+1,432,224$25,780,03218,503,128 total(indirect: See Footnote)
Transactions
  • Conversion

    Common Stock

    2025-02-03+7,523,6827,523,682 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,731 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+789,998$14,219,9648,313,680 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2025-02-03+16,006,94917,070,904 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,730 underlying)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+1,432,224$25,780,03218,503,128 total(indirect: See Footnote)
  • Conversion

    Series Seed Preferred Stock

    2025-02-0319,933,3330 total(indirect: See Footnote)
    Common Stock (8,483,268 underlying)
Transactions
  • Conversion

    Common Stock

    2025-02-03+16,006,94917,070,904 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2025-02-03+7,523,6827,523,682 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,730 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,731 underlying)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+1,432,224$25,780,03218,503,128 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+789,998$14,219,9648,313,680 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
  • Conversion

    Series Seed Preferred Stock

    2025-02-0319,933,3330 total(indirect: See Footnote)
    Common Stock (8,483,268 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
Transactions
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+1,432,224$25,780,03218,503,128 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,730 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
  • Conversion

    Common Stock

    2025-02-03+16,006,94917,070,904 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+789,998$14,219,9648,313,680 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,731 underlying)
  • Conversion

    Common Stock

    2025-02-03+7,523,6827,523,682 total(indirect: See Footnote)
  • Conversion

    Series Seed Preferred Stock

    2025-02-0319,933,3330 total(indirect: See Footnote)
    Common Stock (8,483,268 underlying)
Transactions
  • Conversion

    Series Seed Preferred Stock

    2025-02-0319,933,3330 total(indirect: See Footnote)
    Common Stock (8,483,268 underlying)
  • Conversion

    Common Stock

    2025-02-03+7,523,6827,523,682 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+1,432,224$25,780,03218,503,128 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+789,998$14,219,9648,313,680 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,731 underlying)
  • Conversion

    Common Stock

    2025-02-03+16,006,94917,070,904 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,730 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
CRANDELL KEITH
Director10% Owner
Transactions
  • Conversion

    Series Seed Preferred Stock

    2025-02-0319,933,3330 total(indirect: See Footnote)
    Common Stock (8,483,268 underlying)
  • Conversion

    Common Stock

    2025-02-03+16,006,94917,070,904 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2025-02-03+7,523,6827,523,682 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+1,432,224$25,780,03218,503,128 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+789,998$14,219,9648,313,680 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,730 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,731 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
GILLIS STEVEN
Director10% Owner
Transactions
  • Conversion

    Common Stock

    2025-02-03+16,006,94917,070,904 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
  • Conversion

    Series Seed Preferred Stock

    2025-02-0319,933,3330 total(indirect: See Footnote)
    Common Stock (8,483,268 underlying)
  • Conversion

    Common Stock

    2025-02-03+7,523,6827,523,682 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,730 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,731 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+1,432,224$25,780,03218,503,128 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+789,998$14,219,9648,313,680 total(indirect: See Footnote)
NELSEN ROBERT
Director10% Owner
Transactions
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
  • Conversion

    Common Stock

    2025-02-03+16,006,94917,070,904 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+1,432,224$25,780,03218,503,128 total(indirect: See Footnote)
  • Conversion

    Series Seed Preferred Stock

    2025-02-0319,933,3330 total(indirect: See Footnote)
    Common Stock (8,483,268 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2025-02-032,678,5710 total(indirect: See Footnote)
    Common Stock (1,139,951 underlying)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,731 underlying)
  • Conversion

    Common Stock

    2025-02-03+7,523,6827,523,682 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2025-02-03$18.00/sh+789,998$14,219,9648,313,680 total(indirect: See Footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2025-02-0315,000,0000 total(indirect: See Footnote)
    Common Stock (6,383,730 underlying)
Footnotes (4)
  • [F1]The shares of Issuer's preferred stock have no expiration date and are convertible at the holder's election into Issuer's common stock at a conversion ratio of 1-for-2.349723. The preferred stock automatically converted into shares of the Issuer's common stock, for no additional consideration, upon the closing of the Issuer's initial public offering.
  • [F2]Represents shares held directly by ARCH Venture Fund XII, L.P ("ARCH Venture Fund XII"). ARCH Venture Partners XII, L.P. ("AVP XII LP"), as the sole general partner of ARCH Venture Fund XII, may be deemed to beneficially own the shares held by ARCH Venture Fund XII. ARCH Venture Partners XII, LLC ("AVP XII LLC"), as the sole general partner of AVP XII LP, may be deemed to beneficially own the shares held by ARCH Venture Fund XII. AVP XII LP and AVP XII LLC disclaim beneficial ownership except to the extent of any pecuniary interest therein. As members of the investment committee of AVP XII LLC, each of Kristina M. Burow, Keith Crandell, Steven Gillis and Robert Nelsen (the "AVP XII Committee Members") may also be deemed to share the power to direct the disposition and vote of the ARCH Venture Fund XII shares. Each AVP XII Committee Member disclaims beneficial ownership except to the extent of any pecuniary interest therein.
  • [F3]Represents shares held directly by ARCH Venture Fund XIII, L.P.("ARCH Venture Fund XIII"). ARCH Venture Partners XIII, L.P. ("AVP XIII LP"), as the sole general partner of ARCH Venture Fund XIII, may be deemed to beneficially own the shares held by ARCH Venture Fund XIII. ARCH Venture Partners XIII, LLC ("AVP XIII LLC"), as the sole general partner of AVP XIII LP, may be deemed to beneficially own the shares held by ARCH Venture Fund XIII. AVP XIII LP and AVP XIII LLC disclaim beneficial ownership except to the extent of any pecuniary interest therein. As members of the investment committee of AVP XIII LLC, each of Paul L. Berns, Kristina M. Burow, Keith Crandell, Steven Gillis and Robert Nelsen (the "AVP XIII Committee Members") may also be deemed to share the power to direct the disposition and vote of the ARCH Venture Fund XIII shares. Each AVP XIII Committee Member disclaims beneficial ownership except to the extent of any pecuniary interest therein.
  • [F4](Continued from footnote 3) Each of Kristina Burow and Paul Berns has filed a separate Form 4.

Documents

1 file

Issuer

Metsera, Inc.

CIK 0002040807

Entity typeother

Related Parties

1
  • filerCIK 0001219039

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:01 PM ET
Size
36.2 KB